STAB1 and neoplasm: Using CRISPR/Cas9, we inactivated Stabilin-1, and found that its absence affected neither tumor size nor epithelial characteristics but was associated with a decrease in the intratumoral CD4+/CD8+ T-cell ratio, thereby supporting a potential immunosuppressive role for the STABILIN-1 macrophages.